Research
Library of Existing Research
All 14 published papers on XLID98 / NEXMIF in our library, newest first. Each title opens the paper, and a plain-language summary sits beneath it.
-
NEXMIF dosage and the developing brain (opens in a new tab)
Odamah K, et al. · Frontiers in Neuroscience · 2025
A companion 2025 study confirming the "Goldilocks" warning that too much NEXMIF is also harmful: the aim of any therapy is to restore normal levels, not exceed them.
-
Reactivating the silenced healthy copy of NEXMIF in female-model cells (opens in a new tab)
et al. · bioRxiv preprint (preliminary, not yet peer-reviewed) · 2025
A very recent, not-yet-peer-reviewed preprint reactivating the silenced healthy copy of the gene in female-model cells, the laboratory result behind the conference's CRISPR-activation work.
-
Restoring NEXMIF expression rescues synaptic and behavioral deficits (opens in a new tab)
Odamah K, et al. · Translational Psychiatry · 2025
Restoring NEXMIF in newborn knockout mice brought back normal brain-cell maturation and improved social behaviour, repetitive behaviour, and learning, showing that at least some effects are reversible. The gene was delivered with a lentivirus, a lab tool rather than a therapy suitable for patients, and whether starting later works as well is still unknown.
-
Loss of Nexmif results in the expression of phenotypic variability and loss of genomic integrity (opens in a new tab)
Stekelenburg C, et al. · Scientific Reports · 2022
Looks beyond the brain. Two people with NEXMIF changes also had diabetes, and mice without the gene had fewer dividing insulin-producing cells in the pancreas. The authors suggest NEXMIF may help keep the genome stable; this is early lab work and what it means for people is not yet clear.
-
NEXMIF encephalopathy: an X-linked disorder with male and female phenotypic patterns (opens in a new tab)
Stamberger H, et al. · Genetics in Medicine · 2021
The largest cohort to date (87 individuals: 63 female, 24 male). Developmental delay/intellectual disability was present in ~99% and epilepsy in ~83%; severity is highly variable.
-
The role of autism gene NEXMIF in neuronal development, synapse formation, and behaviors (opens in a new tab)
O'Connor M · Boston University (PhD dissertation) · 2021
A PhD dissertation from Dr. Hengye Man's lab at Boston University. Mice lacking NEXMIF showed autism-like behaviours, and their brain cells grew fewer connections; female mice missing one copy were affected too, with changes in neurons that did and did not make the protein.
-
Nexmif/Kidlia knock-out mouse demonstrates autism-like behaviors, memory deficits, and impairments in synapse and circuit function (opens in a new tab)
Gilbert J, et al. · The Journal of Neuroscience · 2020
A NEXMIF "knockout" mouse reproduces the human picture: autism-like behaviour, memory problems, and disrupted connections between brain cells.
-
Clinical spectrum of KIAA2022 pathogenic variants in males: Case report of two boys with KIAA2022 pathogenic variants and review of the literature (opens in a new tab)
Lorenzo M, et al. · American Journal of Medical Genetics Part A · 2018
Describes two boys with a change in KIAA2022 (now called NEXMIF) and gathers what was known about every male reported so far. Both had profound intellectual disability, limited speech, and autistic behaviour, along with digestive, vision, and temperature-regulation issues that may help doctors anticipate care needs. The report also notes how social media helped the families find one another.
-
Prevalence of Pathogenic Copy Number Variation in Adults With Pediatric-Onset Epilepsy and Intellectual Disability (opens in a new tab)
Borlot F, et al. · JAMA Neurology · 2017
Genetic testing (microarray) of 143 adults with childhood-onset epilepsy and intellectual disability found a likely cause in about 1 in 6. Among the findings, a deletion including KIAA2022 (now called NEXMIF) was linked to Jeavons syndrome, a form of epilepsy with eyelid flickering and absence seizures, a reminder that adults can benefit from testing too.
-
De novo loss of function mutations in KIAA2022 are associated with epilepsy and neurodevelopmental delay in females (opens in a new tab)
Webster R, et al. · Clinical Genetics · 2016
Five unrelated girls with a new (de novo) change in KIAA2022 (now called NEXMIF), found by exome sequencing, all had intellectual disability, hard-to-treat epilepsy, and language difficulties, of similar severity to boys. One of the early reports showing that girls can be affected, not only boys.
-
De novo mutations of KIAA2022 in females cause intellectual disability and intractable epilepsy (opens in a new tab)
de Lange IM, et al. · Journal of Medical Genetics · 2016
Fourteen girls and women with a new (de novo) change in KIAA2022 (now called NEXMIF), most with intellectual disability and seizures that were hard to control. It established that females are often affected, and that epilepsy can be more prominent in females than in males.
-
KIAA2022 Nonsense Mutation in a Symptomatic Female (opens in a new tab)
Farach LS, Northrup H · American Journal of Medical Genetics Part A · 2016
A case report of a 17-year-old girl with a new change in KIAA2022 (now called NEXMIF), intellectual disability, epilepsy, and autistic behaviour. It challenged the earlier view that only boys are affected, which matters for genetic testing and counselling.
-
Delineation of the KIAA2022 Mutation Phenotype: Two Patients with X-linked Intellectual Disability and Distinctive Features (opens in a new tab)
Kuroda Y, et al. · American Journal of Medical Genetics Part A · 2015
Two unrelated boys in Japan with a new change in KIAA2022 (now called NEXMIF), both with severe intellectual disability, autistic behaviour, and low muscle tone, and a set of shared facial features. One of the early reports confirming the gene as a cause of X-linked intellectual disability.
-
A mixed modality approach towards Xi reactivation for Rett syndrome and other X-linked disorders (opens in a new tab)
Carrette LLG, et al. · Proceedings of the National Academy of Sciences (PNAS)
Lab and mouse research on waking up the silenced healthy copy of an X-linked gene in females, shown here for Rett syndrome. Combining two treatments switched the healthy copy back on strongly in cells, and in mice without evident toxicity; the same idea is one route being explored for girls and women with NEXMIF changes.